How to buy Mach7 Technologies shares | A$1.005
Own Mach7 Technologies shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder.
Mach7 Technologies Limited is a health information services business based in Australia. Mach7 Technologies shares (M7T) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $1.005 – a decrease of 7.8% over the previous week. Mach7 Technologies has a trailing 12-month revenue of around $18.9 million.
How to buy shares in Mach7 Technologies
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Mach7 Technologies . Find the share by name or ticker symbol: M7T. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Mach7 Technologies reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $1.005, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Mach7 Technologies . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
What's in this guide?
- Mach7 Technologies key stats
- Compare share trading platforms
- Is Mach7 Technologies stock a buy or sell?
- Mach7 Technologies performance over time
- Are Mach7 Technologies shares over-valued?
- Mach7 Technologies 's financials
- How volatile are Mach7 Technologies shares?
- Does Mach7 Technologies pay a dividend?
- Have Mach7 Technologies shares ever split?
- Other common questions
How has coronavirus impacted Mach7 Technologies 's share price?
Since the stock market crash in March caused by coronavirus, Mach7 Technologies 's share price has had significant positive movement.
Its last market close was $1.005, which is 10.45% up on its pre-crash value of $0.9 and 171.62% up on the lowest point reached during the March crash when the shares fell as low as $0.37.
If you had bought $1,000 worth of Mach7 Technologies shares at the start of February 2020, those shares would have been worth $472.05 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,248.45.
Mach7 Technologies share priceUse our graph to track the performance of M7T stocks over time.
Mach7 Technologies shares at a glance
|Latest market close||AUDA$1.005|
|52-week range||AUDA$0.37 - AUDA$1.185|
|50-day moving average||AUDA$1.0556|
|200-day moving average||AUDA$0.856|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$0.001|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Mach7 Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Mach7 Technologies price performance over time
|1 week (2020-10-23)||3.08%|
|1 month (2020-09-30)||-9.46%|
|3 months (2020-07-30)||5.24%|
|6 months (2020-04-30)||70.34%|
|1 year (2019-10-30)||57.03%|
|2 years (2018-10-30)||318.75%|
|3 years (2017-10-30)||458.33%|
|5 years (2015-10-30)||27.22%|
Is Mach7 Technologies under- or over-valued?
Valuing Mach7 Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mach7 Technologies 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Mach7 Technologies 's P/E ratio
Mach7 Technologies 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1090x. In other words, Mach7 Technologies shares trade at around 1090x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Mach7 Technologies 's EBITDA
Mach7 Technologies 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 million.
The EBITDA is a measure of a Mach7 Technologies 's overall financial performance and is widely used to measure a its profitability.
Mach7 Technologies financials
|Revenue TTM||$18.9 million|
|Gross profit TTM||$6.3 million|
|Return on assets TTM||-1.29%|
|Return on equity TTM||0.53%|
|Market capitalisation||$236.9 million|
TTM: trailing 12 months
Mach7 Technologies share dividends
We're not expecting Mach7 Technologies to pay a dividend over the next 12 months.
Have Mach7 Technologies 's shares ever split?
Mach7 Technologies 's shares were split on a 1:10 basis on 10 January 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Mach7 Technologies shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Mach7 Technologies shares which in turn could have impacted Mach7 Technologies 's share price.
Mach7 Technologies share price volatility
Over the last 12 months, Mach7 Technologies 's shares have ranged in value from as little as $0.37 up to $1.185. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Mach7 Technologies 's is 1.1868. This would suggest that Mach7 Technologies 's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Mach7 Technologies overview
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. The company operates through two segments, Sale of Software Licenses and Provision of Professional Services. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that includes a suite of solutions to drive specialty workflows. The company's Diagnostic Studio solutions include PACS and QC solution; and Universal Worklist. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products, as well as iModality, a mobile medical image capture using smart device technology. Further, the company provides professional services, such as implementation and training, data migration, support, and maintenance services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.
Frequently asked questions
More guides on Finder
How to invest in the Youfoodz (M7T.AU) IPO
Everything we know about the Youfoodz IPO, plus information on how to buy in.
How to invest in the Hipages (M7T.AU) IPO
Everything we know about the Hipages IPO, plus information on how to buy in.
How to buy the US Vegan Climate ETF | N/AN/A
Steps to owning and managing buy US Vegan Climate ETF units.
How to buy Roots Sustainable Agricultural Technologies shares | A$0.023
Steps to owning and managing Roots Sustainable Agricultural Technologies shares from Australia.
How to buy Mach7 Technologies shares | $58.29
Steps to owning and managing Bunge Ltd shares from Australia.
How to buy Mach7 Technologies shares | $37.47
Steps to owning and managing Conagra Brands shares from Australia.
How to buy Mach7 Technologies shares | $67.1
Steps to owning and managing Kellogg Company shares from Australia.
How to buy Mach7 Technologies shares | $71.62
Steps to owning and managing Ingredion shares from Australia
How to buy Mach7 Technologies shares | $59.71
Steps to owning and managing Tyson Foods shares from Australia.
Where to buy wrapper & band sorter racks online in Australia
A list of stores to buy wrapper & band sorter racks online in Australia.
Ask an Expert